BLOCK IgE; UNLOCK LIFE in 3 indications

Omalizumab IN CSU: PREDICTORS AND DOSE SELECTION

Download

Speaker's slide: Lt.Col. Yiwa Suksawat: Severe allergic asthma 6 years of age and above

Download

Omalizumab: Anti-IgE for Nasal Polyps

Download

Rating:

FA-11312659

Ask Speakers

Latest Content

June 13, 2024

Novartis Transplantation Day: My Own Experience with Everolimus on Early Conversion in Kidney Transplantation

Enhancing Kidney Transplantation Management with mTORI //--> 30 min 45 sec Novartis Transplantation Day: My Own Experience with Everolimus on Early Conversion in Kidney Transplantation

Prof. Steven Chadban, MD.Show More

HF Joint Venture Management of Heart failure & Role of ARNI //--> 31 min 02 sec Part 1: Cardiology Quiz from Lesson to Real Practice

Dr. Punchanit Wanichsetakul, M.D. Cardiologist, Thammasat University Hospital

//--> 29 min 51 sec Part 2: Hemodynamic Tracing

Dr. Purich Surunchupakorn, M.D. Cardiologist, Central Chest Institute of Thailand

//--> 23 min 54 sec Part 3: BasicShow More

Oncology Publication

Aug 2020

The NCI-MATCH trial: lessons for precision oncology Checkout

Nov 2021

Dabrafenib plus trametinib in BRAF ^V600E-mutated rare cancers: the phase 2 ROAR trialShow More

Melanoma Publication

Jun 2024

ASCO 2024: Long-term follow up COMBI-AD

Final results of the COMBI-AD study

Checkout

July 2023

MEKINIST® (trametinib)

Sharing Insights in Identifying High Risk PV Patient with splenomegaly //--> 2 min 26 sec PV Expert Connect: Treating High Risk PV with Leukocytosis

Claire Harrison, MD Consultant Haematologist and Deputy Director Guy's and St. Thomas NHS Foundation Trust UK.

Sharing Insights in Identifying High Risk PV Patient with splenomegaly //--> 3 min 50 sec PV Expert Connect: PV Patient with Splenomegaly

Claire Harrison, MD Consultant Haematologist and Deputy Director Guy's and St. Thomas NHS Foundation Trust UK.

page of 40

BLOCK-IgE-UNLOCK-LIFE-indications.jpg

BLOCK IgE; UNLOCK LIFE in 3 indications

Omalizumab IN CSU: PREDICTORS AND DOSE SELECTION

Speaker's slide: Lt.Col. Yiwa Suksawat: Severe allergic asthma 6 years of age and above

Omalizumab: Anti-IgE for Nasal Polyps

Ask Speakers

Novartis Transplantation Day: My Own Experience with Everolimus on Early Conversion in Kidney Transplantation

HF Joint Venture EP.1

Oncology Publication

Melanoma Publication

High Risk PV Patients with Splenomegaly Episode 3

High Risk PV Patients with Splenomegaly Episode 2

Omalizumab IN CSU: PREDICTORS AND DOSE SELECTION

Speaker's slide: Lt.Col. Yiwa Suksawat: Severe allergic asthma 6 years of age and above

Omalizumab: Anti-IgE for Nasal Polyps

Medical Information Request

Ask Speakers